WNK2 and Insulin resistance: Hyperinsulinemia as a compensation for insulin resistance activates insulin receptor substrate-1, together with the downstream mitogen-activated protein kinase and phosphatidylinositol-3 kinase/Akt pathway, which could subsequently activate peroxisome proliferator activated receptor γ [32].